Adjuvanted Virus-Mimicking Nanoparticle HIV Vaccine

NIH RePORTER · NIH · N43 · $300,000 · view on reporter.nih.gov ↗

Abstract

Particle-based Co-delivery of HIV immunogens as Next-generation HIV Vaccines: Tailored immunogens (such as Envs, monomers, native and/or native-like trimers, nucleic acids/RNA such as mRNAs, self-amplifying RNAs) combined with an effective multivalent antigenic display on nanoparticles for delivery may provide a strategy to promote strong and long-lived neutralizing antibody responses against HIV and direct affinity maturation toward HIV neutralizing antibodies. The objective of this contract is to develop a novel nanoparticle delivery system to elicit potent and long-lasting antibody response and broadly neutralizing activity against HIV.

Key facts

NIH application ID
10441667
Project number
75N93021C00025-0-9999-1
Recipient
ZYMERON CORPORATION
Principal Investigator
XU LI
Activity code
N43
Funding institute
NIH
Fiscal year
2021
Award amount
$300,000
Award type
Project period
2021-07-01 → 2022-06-30